Skip to content
ppharmaranks
Menu

Famotidine: uses, dosing, side effects & brands

Famotidine is a histamine-2 receptor antagonist sold in the U.S. under 7 brand and generic names, for duodenal ulcer, dyspepsia and peptic esophagitis. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.

By the pharmaranks editorial teamReviewed against the FDA (openFDA label, NDC Directory & Enforcement) sourcesUpdated Jul 24, 2026How we research

Key facts

Drug class
Histamine-2 Receptor Antagonist
Treats (across its forms)
Duodenal Ulcer, Dyspepsia and Peptic Esophagitis
Available as
Injectable · Solution · Powder · Tablet · Tablet, orally disintegrating
Sold as
7 products — Famotidine, Fluxid and Pepcid Ac, and others
Prescription?
Both Rx and OTC forms
Generic available?
Yes
Half-life
2.5 to 3.5 hours
What the pharmacy pays
about $2 for a 30-count supply — not your price

How Famotidine is dosed

From the FDA label for Famotidine (application ANDA217842). Other famotidine products — different forms, different strengths — are dosed differently. Follow the label for the one you were prescribed.

Recommended adult dosage by indication ( 2.1 ): Active DU 40 mg once daily; or 20 mg twice daily Active GU 40 mg once daily Symptomatic Nonerosive GERD 20 mg twice daily Erosive Esophagitis due to GERD 20 mg twice daily; or 40 mg twice daily Pathological Hypersecretory Conditions 20 mg every 6 hours; adjust to patient needs; maximum 160 mg every 6 hours Risk Reduction of DU Recurrence 20 mg once daily Recommended pediatric dosage by indication ( 2.2 ): Peptic Ulcer Disease 1 year to less than 17 years Starting dosage 0.5 mg/kg once daily; or 0.25 mg/kg twice daily; may increase to 1 mg/kg once daily at bedtime or 0.5 mg/kg twice daily; Maximum of 40 mg per day GERD Birth to less than 3 months Starting dosage 0.5 mg/kg once daily; may increase to 1 mg/kg once daily 3 months to less than 1 year Starting dosage 0.5 mg/kg twice daily; may increase to 1 mg/kg twice daily; Maximum of 40 mg per day GERD with or without esophagitis and ulcerations 1 year to less than 17 years 0.5 mg/kg twice daily Maximum of 40 mg twice daily See full prescribing information for complete dosing information in adults and pediatrics, recommended treatment duration by indication, and dosage adjustment for adult patients with renal impairment. ( 2.1 , 2.2 , 2.3 ) Administration ( 2.4 ): Take once daily before bedtime or twice daily in the morning and before bedtime with or without food. 2.1 Recommended…

Everything below is the FDA label for Famotidine (injectable, solution, powder, tablet). Famotidine is also sold as tablet, orally disintegrating, and those are different medicines to take — follow the label for the one you were prescribed.

Famotidine side effects

The most common adverse reactions are: headache, dizziness, constipation, and diarrhea. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trial Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The safety of famotidine for oral suspension has been established based on adequate and well-controlled studies of another oral famotidine product [see Clinical Studies ( 14 )]. The following is a summary of the adverse reactions reported in those studies. Oral famotidine was studied in 7 U.S. and international placebo- and active-controlled trials in approximately 2500 patients [see Clinical Studies ( 14 )] . A total of 1442 patients were treated with famotidine, including 302 treated with 40 mg twice daily, 456 treated with 20 mg twice daily, 461 treated with 40 mg once daily, and 396 treated with 20 mg once daily. The population was 17 to 91 years old, fairly well distributed between sex and race; however, the predominant race was White. The following adverse reactions occurred in greater than or equal to 1% of famotidine-treated patients: headache, dizziness…

Who shouldn’t take Famotidine

Famotidine for oral suspension is contraindicated in patients with a history of serious hypersensitivity reactions (e.g., anaphylaxis) to famotidine or other H 2 -receptor antagonists. History of serious hypersensitivity reactions (e.g., anaphylaxis) to famotidine or other H 2 -receptor antagonists. ( 4 )

Famotidine drug interactions

Drugs Dependent on Gastric pH for Absorption : Systemic exposure of the concomitant drug may be significantly reduced leading to loss of efficacy. ( 7.1 ) • Tizanidine (CYP1A2) Substrate : Potential for substantial increases in blood concentrations of tizanidine resulting in hypotension, bradycardia or excessive drowsiness; avoid concomitant use, if possible. ( 7.2 ) 7.1 Drugs Dependent on Gastric pH for Absorption Famotidine can reduce the absorption of other drugs due to its effect on reducing intragastric acidity, leading to loss of efficacy of the concomitant drug. Concomitant administration of famotidine for oral suspension with dasatinib, delavirdine mesylate, cefditoren, and fosamprenavir is not recommended. See the prescribing information for other drugs dependent on gastric pH for absorption for administration instructions, including atazanavir, erlotinib, ketoconazole, itraconazole, ledipasvir/sofosbuvir, nilotinib, and rilpivirine. 7.2 Tizanidine (CYP1A2 Substrate) Although not studied clinically, famotidine is considered a weak CYP1A2 inhibitor and may lead to substantial increases in blood concentrations of tizanidine, a CYP1A2 substrate. Avoid concomitant use with famotidine for oral suspension. If concomitant use is necessary, monitor for hypotension, bradycardia or excessive drowsiness. Refer to the full prescribing information for tizanidine.

Can you take famotidine with…?

Source-cited answers for the combinations people actually ask about — each with a verdict and what to watch for.

Every famotidine product we track (7)

Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.

Famotidine products
#DrugRatingPharmacy pays
170/100$2View →
270/100$2View →
370/100$2View →
470/100$2View →
570/100$2View →
670/100$2View →
7Not yet rated$2View →

What famotidine pills look like

Imprint codes, colour and shape from the FDA’s labelling data. Match the imprint on your pill — or search any imprint.

Famotidine pill imprints
ImprintStrengthColourShape
CC;5810 mgpinkround
CC;5920 mgyellowround
CC;6020 mgyellowsquare
Z4140 mgwhiteround
777800 mg / 26.6 mgwhitecapsule
IF826800 mg / 26.6 mgblueoval

Combination products containing famotidine

A combination is a different drug — different dosing, different warnings. It is listed here so you can find it, not so you can substitute it.

Famotidine recalls

From the FDA Enforcement database. A recall covers specific lots — not the drug as a whole.

How long famotidine keeps

The date on a sealed pack is not the only one: some famotidine labels start a second clock once the product is opened or mixed, as short as 48 hours.

Does famotidine expire? The in-use limits and storage rules from its labels

Famotidine and breastfeeding

From LactMed, the US National Library of Medicine’s Drugs and Lactation Database — quoted, not rewritten.

Famotidine doses in breastmilk result in infant dosages that are lower than those used in newborn infants. Famotidine would not be expected to cause any adverse effects in breastfed infants. No special precautions are required.

Full LactMed record for famotidine: levels in milk, effects in breastfed infants, and the drugs it would consider instead

National Institute of Child Health and Human Development, record revised August 15, 2024. LactMed states its information is not a substitute for professional judgement.

What people report to the FDA about famotidine

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 79,544 reports naming famotidine, and the FDA flagged 68% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • nausea5,134 reports
  • fatigue4,836 reports
  • diarrhoea4,792 reports
  • dyspnoea3,792 reports
  • chronic kidney disease3,764 reports
  • headache3,442 reports
  • vomiting3,151 reports
  • acute kidney injury2,934 reports

Read these as a signal, not a rate. A report does not mean famotidine caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.

Source: openFDA drug/event (FAERS), retrieved August 25, 2026.

How long famotidine stays in your system

The elimination half-life of famotidine is 2.5 to 3.5 hours. This is the elimination half-life stated in §12.3 of the FDA label for adults with normal organ function; the label reports a single elimination half-life and does not separate a distribution from a terminal phase. Famotidine is not a prodrug, and it has no active metabolite that outlasts it — the label says the only metabolite identified in humans is the S-oxide, and famotidine undergoes minimal first-pass metabolism, with 25-30% of an oral dose recovered in urine unchanged. Kidney impairment: famotidine is cleared mostly by the kidneys (65-70% renal), and clearance falls in kidney impairment, so the drug lingers longer. The current label quantifies this as exposure rather than half-life — AUC increases at least 2-fold with moderate impairment (creatinine clearance 30-60 mL/min) and at least 5-fold with severe impairment (below 30 mL/min) — and it does not state a specific prolonged half-life number, so none is given here. Older adults: the label names no separate half-life, but notes famotidine is substantially excreted by the kidney and that risk of adverse reactions may be greater in elderly patients, particularly those with impaired renal function. Liver impairment: this label states no hepatic pharmacokinetic data and no half-life for liver impairment.

DailyMed - FAMOTIDINE tablet, film coated (FDA label, revised 11/2021), §12.3 Pharmacokinetics

Half-life is how long the body takes to clear half a dose. It is not the same as how long a drug test can detect it, and it varies with age, kidney and liver function.

Is famotidine safe during pregnancy?

The label says the data are limited

The label's §8.1 risk summary states that available data with H2-receptor antagonists, including famotidine, in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. Animal reproduction studies in rats and rabbits revealed no significant evidence of impaired fertility or harm to the fetus, though there are no adequate or well-controlled studies in pregnant women. Because animal studies are not always predictive, the label says the drug should be used during pregnancy only if clearly needed. Discuss use in pregnancy with your prescriber.

This is what famotidine’s FDA label says — not a recommendation to take or stop it. In pregnancy, that decision is your prescriber’s; do not start or stop a medicine on your own.

Famotidine - DailyMed FDA Label

Related guides

Related calculators

Frequently asked questions

What is Famotidine?

Famotidine is a histamine-2 receptor antagonist used to treat Duodenal Ulcer, Dyspepsia, Peptic Esophagitis, Gastroesophageal Reflux.

What kind of drug is famotidine?

The FDA classifies famotidine as a histamine-2 receptor antagonist. If you are checking whether it is safe to combine with something else, the class is what matters — two drugs from the same class usually should not be stacked.

Is famotidine safe during pregnancy?

The label's §8.1 risk summary states that available data with H2-receptor antagonists, including famotidine, in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. Animal reproduction studies in rats and rabbits revealed no significant evidence of impaired fertility or harm to the fetus, though there are no adequate or well-controlled studies in pregnant women. Because animal studies are not always predictive, the label says the drug should be used during pregnancy only if clearly needed. Discuss use in pregnancy with your prescriber. This is what famotidine's FDA label says; whether to use it in pregnancy is your prescriber's decision.

How long does famotidine stay in your system?

The elimination half-life of famotidine is 2.5 to 3.5 hours — that is how long the body takes to clear half of a dose. This is the elimination half-life stated in §12.3 of the FDA label for adults with normal organ function; the label reports a single elimination half-life and does not separate a distribution from a terminal phase. Famotidine is not a prodrug, and it has no active metabolite that outlasts it — the label says the only metabolite identified in humans is the S-oxide, and famotidine undergoes minimal first-pass metabolism, with 25-30% of an oral dose recovered in urine unchanged. Kidney impairment: famotidine is cleared mostly by the kidneys (65-70% renal), and clearance falls in kidney impairment, so the drug lingers longer. The current label quantifies this as exposure rather than half-life — AUC increases at least 2-fold with moderate impairment (creatinine clearance 30-60 mL/min) and at least 5-fold with severe impairment (below 30 mL/min) — and it does not state a specific prolonged half-life number, so none is given here. Older adults: the label names no separate half-life, but notes famotidine is substantially excreted by the kidney and that risk of adverse reactions may be greater in elderly patients, particularly those with impaired renal function. Liver impairment: this label states no hepatic pharmacokinetic data and no half-life for liver impairment. Half-life is not the same as how long a drug test can detect the drug, and it varies with age, kidney and liver function.

Can you take famotidine with other medicines?

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run famotidine against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

What brand names is famotidine sold under?

We track 7 famotidine-containing products in the U.S.: Famotidine, Fluxid, Pepcid Ac, Pepcid Preservative Free, Pepcid Preservative Free in Plastic Container, Pepcid Rpd and Pepcid. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.

What forms does famotidine come in?

Across the brands we track, famotidine is currently marketed as injectable, solution, powder, tablet and tablet, orally disintegrating, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Is there a generic famotidine?

Yes. Our catalog lists 1 generic famotidine product alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.

Has famotidine been recalled?

The FDA's Enforcement database lists 1 recall record whose product description mentions famotidine. The most recent: Famotidine Injection (Nov 6, 2025). A recall applies to specific lots, not to the drug as a whole — check the record for the affected lot numbers.

What should I avoid while taking famotidine?

Other medicines: we hold source-cited interaction answers for Can you take famotidine with omeprazole? and Can you take Tums and Pepcid together?. This is what the FDA label and our cited sources say — it is not a complete list. Your pharmacist can check your own combination.

What is famotidine used for?

Famotidine is an H2 blocker that reduces stomach acid. Over-the-counter, it's approved to relieve and prevent heartburn and acid indigestion (sold as Pepcid AC and store brands). By prescription, it's FDA-approved to treat and prevent stomach and duodenal ulcers, treat gastroesophageal reflux disease (GERD) including erosion of the esophagus, and manage rare conditions that cause the stomach to make too much acid, such as Zollinger-Ellison syndrome. It works by blocking histamine's signal to acid-producing cells in the stomach lining.

How is famotidine different from omeprazole (a PPI)?

Both cut stomach acid, but they work differently and at different speeds. Famotidine is an H2 blocker that starts working within about an hour and is good for occasional or as-needed heartburn. Omeprazole and other proton pump inhibitors (PPIs) shut down acid production more completely but take one to four days to reach full effect, so they're used for frequent heartburn (two or more days a week) and for healing conditions like erosive esophagitis. Some people use famotidine for quick, situational relief and a PPI for ongoing daily control.

Is famotidine used for allergic reactions or hives?

Yes, but as an off-label add-on rather than an FDA-approved use. Because famotidine blocks histamine at H2 receptors, doctors sometimes combine it with a standard H1 antihistamine (like cetirizine or diphenhydramine) for hives (urticaria) or as premedication before infusions to blunt allergic reactions. On its own it is not a treatment for a serious allergic reaction — anaphylaxis is a medical emergency treated with epinephrine. Use famotidine this way only under a clinician's direction.

Cite this page
APA
pharmaranks. (2026, July 24). Famotidine: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/famotidine
MLA
“Famotidine: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/famotidine.

We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.

Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.

Read the full FDA label for famotidine on DailyMed (NIH) ↗.